干细胞移植对大鼠青光眼模型视神经保护作用及安全性的Meta分析

doi:10.6040/j.issn.1673-3770.0.2018.594

摘要/Abstract

摘要： 目的系统评价干细胞移植对大鼠青光眼模型的视神经保护作用及其安全性。方法计算机检索PubMed、EMbase、The Cochrane Library、OVID、CBM、中国知网、维普和万方数据,搜集有关干细胞移植治疗青光眼的动物实验,检索时限均从建库起到2018年6月10日。由两名评价员独立的按照纳入和排除标准筛选文献、提取资料,采用SYRCLE动物实验偏倚风险评估表对纳入文献进行偏倚风险评价。采用RevMan 5.3软件进行统计分析。结果最终纳入8个研究,包括319只大鼠。Meta分析研究结果显示,实验组第28天的眼压低于对照组［SMD=-2.12,95%CI(-3.39,-0.85), Z=3.27,P=0.001］;实验组第14、28天视网膜神经节细胞计数高于对照组［SMD=4.51,95%CI(3.17,5.85), Z=6.60,P<0.00 001;SMD=2.96,95%CI(1.11,4.80), Z=3.14,P=0.002］;实验组第14天视网膜BDNF的表达高于对照组［SMD=2.67,95%CI(1.46,3.88), Z=4.32,P<0.0 001］;实验组第21、28天视网膜GDNF表达高于对照组［WMD=1.21,95%CI(1.05,1.37), Z=14.75,P<0.001;WMD=0.79,95%CI(0.52,1.06), Z=5.72,P<0.001］;实验组第14天视网膜IGF-I的表达高于对照组［SMD=4.31,95%CI(2.51,6.11), Z=4.69,P<0.001］;3项研究表明,干细胞可在眼内存活4周,少数可融入宿主视网膜,并表达神经细胞表面标志物;3项研究表明,干细胞眼内移植后无不良反应发生。结论现有证据显示,大鼠青光眼模型构建尚缺乏统一、规范的方法,干细胞移植对大鼠青光眼模型视神经有一定的保护作用,且安全性较高,但受纳入研究数量和质量的限制,上述结论还需更多高质量研究验证。

关键词: 青光眼模型, 干细胞, 随机对照试验, Meta分析, 系统评价

Abstract: Objective To systematically review the neuroprotective effects and safety of transplanted stem cells in rats with experimental glaucoma. Methods Databases including PubMed, Embase, the Cochrane Library, Ovid, CBM, CNKI, VIP, and Wanfang Data were searched to collect information on animal experiments of stem cell transplantation for glaucoma, from inception to June 10, 2018. Two reviewers independently screened the literature in accordance with the inclusion and exclusion criteria, extracted the data, and assessed the risk of bias of the included studies using SYRCLE's risk of bias tool. Subsequently, a meta-analysis was performed using the RevMan 5.3 software. Results A total of 8 studies involving 319 rats were analyzed. The results of the meta-analysis showed that: 1)on the 28th day, the intraocular pressure was lower in the experimental group that in the control group ［SMD=-2.12, 95% CI:(-3.39, -0.85), Z=3.27, P=0.001］; 2)on the 14th day and the 28th day, the retinal ganglion cells were more in the experimental group than in the control group ［SMD=4.51, 95% CI:(3.17, 5.85), Z=6.60, P<0.001; SMD=2.96, 95% CI:(1.11, 4.80), Z=3.14, P=0.002］; 3)on the 14th day, the expression of BDNF was more in the retina of the experimental group than in the control group ［SMD=2.67, 95% CI:(1.46, 3.88), Z=4.32, P<0.001］; 4)on the 14th day and the 28th day, the expression of GDNF was more in the retina of the experimental group than in the control group ［WMD=1.21, 95% CI:(1.05, 1.37), Z=14.75, P<0.001; WMD=0.79, 95% CI:(0.52, 1.06), Z=5.72, P<0.001］; 5)on the 14th day, the expression of IGF-I was more in the retina of the experimental group than in the control group ［SMD=4.31, 95% CI:(2.51, 6.11), Z=4.69, P<0.001］. Three studies showed that stem cells could survive in the eye for 4 weeks and a few cells could integrate in the host retina and express neural cell surface markers. Three studies showed no adverse reactions after transplantation. Conclusions Although the current literature shows no uniform, standardized treatment method for experimental glaucoma in rats, there is evidence that stem cell transplantation has a certain protective effect on the optic nerve of rats with glaucoma, with no adverse reactions after transplantation. Because of the limited quality and quantity of the included literature, further studies are needed to validate the results of this review.

Key words: A rat model of glaucoma, Stem cells, Randomized controlled trial, Meta-analysis, Systematic review

中图分类号:

R775.9

刘琳,郑华,谌绍林,段宣初. 干细胞移植对大鼠青光眼模型视神经保护作用及安全性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 138-144.

LIU Lin, ZHENG Hua, CHEN Shaolin, DUAN Xuanchu. Neuroprotective effects and safety of stem cell transplantation in rats with experimental glaucoma: a systematic review[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 138-144.

参考文献 21

[1]	陶钰, 张士玺, 柴雪荣, 等. 青光眼患者生存质量及其影响因素的临床研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 84-86. doi: 10.6040/j.issn.1673-3770.0.2014.037. TAO Yu, ZHANG Shixi, CHAI Xuerong, et al. Clinical study on glaucoma patients' quality of life and related factors[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2014, 28(2): 84-86. doi: 10.6040/j.issn.1673-3770.0.2014.037.
[2]	Manuguerra-Gagné R, Boulos PR, Ammar A, et al. Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment[J]. Stem Cells, 2013, 31(6): 1136-1148. doi:10.1002/stem.1364.
[3]	Li JY, Li N, Jiang Y. Mesenchymal stem cells secrete brain-derived neurotrophic factor and promote retinal ganglion cell survival after traumatic optic neuropathy[J]. J Craniofac Surg, 2015, 26(2): 548-552. doi:10.1097/SCS.0000000000001348.
[4]	Bull ND, Limb GA, Martin KR. Human Müller stem cell(MIO-M1)transplantation in a rat model of glaucoma: survival, differentiation, and integration[J]. Invest Ophthalmol Vis Sci, 2008, 49(8): 3449-3456. doi:10.1167/iovs.08-1770.
[5]	Johnson TV, Bull ND, Hunt DP, et al. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma[J]. Invest Ophthalmol Vis Sci, 2010, 51(4): 2051-2059. doi:10.1167/iovs.09-4509.
[6]	Zhang Y, Wang W. Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina[J]. Invest Ophthalmol Vis Sci, 2010, 51(7): 3742-3748. doi:10.1167/iovs.08-3314.
[7]	Jiang YF, Zhang Y, Zhang LJ, et al. Therapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in mice[J]. Int J Mol Sci, 2014, 15(6): 9372-9385. doi:10.3390/ijms15069372.
[8]	罗杰,冷卫东.系统评价/Meta分析理论和实践[M].北京:军事医学科学出版社,2015:490.
[9]	Hooijmans CR, Rovers MM, de Vries RB, et al. SYRCLE's risk of bias tool for animal studies[J]. BMC Med Res Methodol, 2014, 14: 43. doi:10.1186/1471-2288-14-43.
[10]	Hu Y, Tan HB, Wang XM, et al. Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma[J]. Clin Interv Aging, 2013, 8: 1467-1470. doi:10.2147/CIA.S47350.
[11]	Zhao TT, Li YQ, Tang LS, et al. Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats[J]. Graefes Arch Clin Exp Ophthalmol, 2011, 249(7): 1021-1028. doi:10.1007/s00417-011-1635-7.
[12]	顾志敏, 周利晓, 齐若, 等. 视网膜干细胞移植对青光眼视网膜神经节细胞的保护[J]. 中国组织工程研究, 2016, 20(28): 4203-4209. doi:10.3969/j.issn.2095-4344.2016.28.015. GU Zhimin, ZHOU Lixiao, QI Ruo, et al. Protective effect of retinal stem cell transplantation on retinal ganglion cells in glaucoma[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(28): 4203-4209. doi:10.3969/j.issn.2095-4344.2016.28.015.
[13]	柳浩然. 神经干细胞移植治疗视神经损伤的实验研究[D]. 长沙: 中南大学, 2006.
[14]	周霞. RSCs移植联合COP-1免疫治疗对青光眼模型鼠RGCs的保护作用[D]. 长沙: 中南大学, 2012.
[15]	Emre E, Yüksel N, Duruksu G, et al. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model. Cytotherapy, 2015, 17(5):543-559.
[16]	王陆飞. 骨髓间充质干细胞向视网膜样结构诱导分化的体外和体内研究[D]. 长春: 吉林大学, 2004.
[17]	Bull ND, Irvine KA, Franklin RJ. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest Ophthalmol Vis Sci, 2009, 50(9):4244-4253.
[18]	刘鸣.系统评价、Meta分析设计与实施方法[M].北京:人民卫生出版社,2011:97-117.
[19]	Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma[J]. Arch Ophthalmol, 2002, 120(6): 701-713; discussion 829-830.
[20]	Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats[J]. Invest Ophthalmol Vis Sci, 2000, 41(11): 3460-3466.
[21]	田方圆, 吴斌, 徐珽. 肝素治疗吸入性肺损伤动物实验的系统评价[J]. 中国循证医学杂志, 2017, 17(6): 705-710. TIAN Fangyuan, WU Bin, XU Ting. Heparin treatment for animal model with smoke inhalation injury: a meta-analysis[J]. Chinese Journal of Evidence-Based Medicine, 2017, 17(6): 705-710.

相关文章 15

[1]	李仕运,谢艳,潘佳煜,陈美馨,龙丹,张春林. 人工耳蜗植入对老年语后聋患者疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 20-30.
[2]	方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73.
[3]	雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67.
[4]	许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[5]	孙春晓,王文晴,岳田,刘济生. 高低累积顺铂剂量同步放化疗治疗鼻咽癌的疗效分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 31-41.
[6]	郑泽皓,魏佳俐,刘嘉涛,周玉麒,孙文婷,李雨轩,白鹏. 特定部位针刺法治疗突发性聋的疗效及安全性评价:一项系统综述和网状Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 114-127.
[7]	于浩南,钟莹莹,王新萌,张敏,姜清敏,李娜,李艳. TNF-α诱导的人脐带间充质干细胞培养基对小鼠角膜缘干细胞缺乏的治疗作用[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 141-147.
[8]	米雪芹,李松哲,邓英杰,李圣洋,肖丁齐,樊磊. 质子泵抑制剂与胃黏膜保护剂治疗咽喉反流性疾病临床疗效及安全性对比的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 136-142.
[9]	王东芳,张清雨,宋继科,毕宏生. 基于CONSORT声明和STRICTA清单评价针刺防控儿童青少年近视随机对照试验的报告质量[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 66-79.
[10]	吴翠萍,朱一丹,李春燕,殷善开. 胆红素对神经干细胞活性和增殖的影响研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 1-6.
[11]	王凯健,陈雪生,王威. 血小板-淋巴细胞比值与喉鳞状细胞癌预后相关性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 67-73.
[12]	李飏,刘鸫,曹文捷. 红光治疗对近视儿童等效球镜度、眼轴长度及脉络膜厚度影响的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 74-81.
[13]	张真,杨卓莹,周佳妮,张大为,陈仁杰. 环索奈德鼻喷剂治疗季节性过敏性鼻炎疗效与安全的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 13-20.
[14]	王明明,罗洋,贺少娟,张现兴,李学忠. 慢性鼻窦炎鼻息肉基底干细胞转录组生物信息学分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 6-15.
[15]	毕晓云,马本绪,王心茹,李旭豪,杨继国. 穴位贴敷治疗小儿过敏性鼻炎随机对照试验的Meta分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 75-85.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed